PENTAX Medical continues its commitment to Endoscopic Ultrasound (EUS) as an indispensable part of its flexible endoscopy portfolio. Pentax recently launched its PENTAX Medical EUS/EBUS-J10* line-up.
In response to the recent change in ownership of the Diagnostic Imaging Business of Hitachi, Ltd. (Hitachi), a long-time research and development partner in EUS, PENTAX Medical assured its customers that PENTAX Medical's commitment to EUS will remain unchanged. Users of PENTAX Medical platforms can continue to expect the same level of product support and future innovation to which they are accustomed.
Under the new ownership structure of Hitachi the company expects its partnership to continue with equal respect and treatment for all partners and customers of Hitachi based on fair competition rules. PENTAX Medical is determined that products, services and support to its customers and partners will not be affected.
"Endoscopic Ultrasound is the gold standard for tumor staging and diagnosis and rapidly advancing into therapy," said Gerry Bottero, Global President, PENTAX Medical. "With our newest innovative solution, we have demonstrated a clear commitment in providing enhanced procedural efficiency and optimized patient care."
PENTAX Medical has a clear goal of expanding the EUS application into new markets, as well as working with more experts in research and education.
Back to News
